Wikidata

(Q113893228)

English

Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)

clinical trial

In more languages

Statements

short name
B-001 (English)
0 references
title
Letrozole With or Without Metronomic Capecitabine in First Line Treatment of Patients With ER-positive HER2 Negative Advanced Breast Cancer: A Randomized Phase II Study. (English)
0 references
country
Egypt
0 references
start time
1 March 2020
0 references
end time
31 October 2021
0 references
number of participants
204
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113893228&oldid=2149399418"